Sign In
Buy PRCT
$16.69
-0.86 (-4.90%)
At Close: Jul 24, 2026
Analysts Estimate PROCEPT BioRobotics Corporation (PRCT) to Report a Decline in Earnings: What to Look Out for
11:26am, Thursday, 20'th Apr 2023
PROCEPT BioRobotics Corporation (PRCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
REDWOOD CITY, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developi
PROCEPT BioRobotics Corp. to Present at the Virtual Key Bank Life Sciences & MedTech Investor Forum
04:05pm, Thursday, 02'nd Mar 2023
REDWOOD CITY, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developi
PROCEPT BioRobotics Corporation (PRCT) Reports Q4 Loss, Tops Revenue Estimates
06:49pm, Tuesday, 28'th Feb 2023
PROCEPT BioRobotics Corporation (PRCT) delivered earnings and revenue surprises of -5.66% and 0.33%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for
PROCEPT BioRobotics Corp. to Present at the 43rd Annual Cowen Health Care Conference in Boston
04:02pm, Monday, 13'th Feb 2023
REDWOOD CITY, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developin
Procept BioRobotics: Positioning Into FY22 Earnings (Technical Analysis)
09:56am, Tuesday, 07'th Feb 2023
PROCEPT BioRobotics endured a volatile start to the new year, eventually breaking above its longer-term resistance line. Market generated data is still supportive for a re-rating heading into its FY22
PROCEPT BioRobotics Corp. to Present at the 41st Annual J.P. Morgan Healthcare Conference
04:05pm, Wednesday, 14'th Dec 2022
REDWOOD CITY, Calif., Dec. 14, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative sol
Procept BioRobotics: Aquablation System Meaningful Insulator
04:20pm, Friday, 18'th Nov 2022
PROCEPT BioRobotics Corporation reported 135% YoY Q3 revenue growth to $20.3mm. Growth was underscored by robotic system sales and utilization from current placements.
PROCEPT BioRobotics Corporation (PRCT) Q3 2022 Earnings Call Transcript
08:22am, Sunday, 06'th Nov 2022
PROCEPT BioRobotics Corporation (NASDAQ:PRCT ) Q3 2022 Earnings Call Conference Call November 3, 2022 4:30 PM ET Company Participants Matt Bacso – Vice President-Investor Relations Reza Zadno – Ch
PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Tops Revenue Estimates
07:36pm, Thursday, 03'rd Nov 2022
PROCEPT BioRobotics Corporation (PRCT) delivered earnings and revenue surprises of -8.51% and 17.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead f
Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year
01:18pm, Wednesday, 05'th Oct 2022
Biotech isn't the only place investors in health care stocks can make money in 2022. Take a look at leading medical-equipment stocks.
Procept BioRobotics Has Resources To Ramp Up Commercialization
03:39pm, Thursday, 01'st Sep 2022
Procept BioRobotics went public in September 2021, raising approximately $164 million in an IPO. The firm is commercializing a water-based ablation device to treat benign prostatic hyperplasia, a comm
PROCEPT BioRobotics Corp. to Present at 2022 Wells Fargo Healthcare Conference
04:03pm, Monday, 22'nd Aug 2022
REDWOOD CITY, Calif., Aug. 22, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative sol
PROCEPT BioRobotics Corporation's (PRCT) CEO Reza Zadno on Q2 2022 Results - Earnings Call Transcript
12:19am, Sunday, 07'th Aug 2022
PROCEPT BioRobotics Corporation (NASDAQ:PRCT ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Matt Bacso - Investor Relations Reza Zadno - Chief Executive Officer Kevi
PROCEPT BioRobotics to Report Second Quarter 2022 Financial Results on August 4, 2022
04:02pm, Thursday, 14'th Jul 2022
REDWOOD CITY, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative sol
